Dr. John Cush RheumNow
7 years 6 months ago
Data from the Osteoarthritis Initiative (n 4369) shows that fluctuating or persistent Knee pain over 1 yr had an increased risk of cartilage volume loss and structural progression over 4 years (OR 1.62, 95% CI 1.04–2.54) https://t.co/Inf4WsQ4Lz
Dr. John Cush RheumNow
7 years 6 months ago
17.6 million adult Americans, 1 of 12, have an alcohol-use disorder, according to the National Council on Alcoholism and Drug Dependence. https://t.co/duojLFsNjD
The American College of Rheumatology Committee on Rheumatologic Care has released new drug pricing and step therapy position statements that they hope legislators will consider as they continue to explore policy and regulatory options to make drugs more affordable and accessible.
Interstitial lung disease (ILD) has been a hot topic in numerous journals recently with reports of increasing incidence and links to disease activity.
Dr. John Cush RheumNow
7 years 6 months ago
Analysis of CareRA, early RA 330 pt trial shows long term outcomes linked to initial response type rather than regimen. Best PROMs in the 42% with early persistent response. 9% were primary NR, 28% secondary NR, 21% delayed responders. https://t.co/ZDqYD3krtb
Dr. John Cush RheumNow
7 years 6 months ago
Long term safety study of 4481 tofacitinib pts w/ 9.5yrs exposure (16,291PYs). 52% discontinued Rx (4% insufficient response; 24% adverse events). AE incidence rates were 3.4/100PY for H zoster, 2.4/100Py SIE, 0.8 cancer, 0.4 MACE, 0.3 Mortality. https://t.co/Qv5keuKXr3
Dr. John Cush RheumNow
7 years 6 months ago
41 study Metanalysis on H zoster drug risk in psoriasis and PsA - finds an increased risk w/ steroids, tofacitinib, biologic +DMARD Combination Rx. But no risk with monotherapy. Insufficient evidence for IL-12/23, -7, -23 inhibitors or apremilast https://t.co/KRrTqIw7Ko
Madelaine Feldman MattieRheumMD
7 years 6 months ago
NSAIDS can reduce fertility in women - from Dr Sammaritano. #RNL2019
7 years 6 months ago
#RNL2019 But ANCA wont completely replace it. (depends on scenario) --Dr Langford https://t.co/rygxJ2EVFR
MedR #QuedateEnCasa MedReuma
7 years 6 months ago
Do female vs. male patients with AS #spondyloarthritis present differently? Dr Husni #RNL2019 https://t.co/ZEGuRzxGUn
Dr. John Cush RheumNow
7 years 6 months ago
Dr Craig Leonardi's review of Effective biologics to achieve a PASI 100 in Psoriasis. The newer agents are far ahead! #RNL2019 https://t.co/p71hb58SAf
Madelaine Feldman MattieRheumMD
7 years 6 months ago
Dining neath the stars with some of my favorite rheumatologists at RheumNow Live @LCalabreseDO @McknightmdEllen #RNL2019 https://t.co/bMNeeyMrf8
MedR #QuedateEnCasa MedReuma
7 years 6 months ago
2016 ASAS-EULAR treatment recommendations for axSpA Dr Ruderman #Spondylitis #RNL2019 https://t.co/NtIPbryT5y
caocosm caocosm
7 years 6 months ago
Reminder on dosing of tocilizumab in GCA #rnl2019 https://t.co/SbExbhfEGg
